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Expression of HLA-DR Antigen in Skin from Patients with Psoriasis 
VERA B_ MORHENN, M.D., ELIZABETH A. ABEL, M.D ., AND GUSTAV MAHRLE, M.D. 
Department of Dermatology, Stanford University School of M edicine, Stanford, California, U.S.A . 
Using murine monoclonal antibodies against human 
HLA-DR antigen and against human T cells, we investi-
gated the indirect immunofluorescence staining pattern 
of involved and uninvolved skin from patients with pso-
riasis. The staining pattern of involved psoriatic epider-
mis is different from the pattern seen in uninvolved skin 
from the same patient and consists of scattered, single 
Hl.A-DR positive cells alternating with groups of HLA-
DR positive cells. These HI...A-DR positive cell clusters 
can be seen at any level of the epidermis. In some pa-
tients, the dermis of involved skin shows prominent 
accumulations ofT cells which are HLA-DR positive and 
thus represent activated T cells. 
On frozen section of normal human epidermis, Langerhans 
cells (LC) are the only cells which express HLA-DR antigen, 
the human analogue of the murine immune response associated 
(Ia) antigen [1-3]. On the other hand, in 2 diseases, lichen 
planus and tumor stage mycosis fungoides, the majority of 
diseased epidermal cells demonstrate HLA-DR antigen [4,5]. 
Thus, epidermal cells other than LC have the capacity to 
express HLA-DR. 
Patients with psoriasis, a disease characterized by epidermal 
cell hyperproliferation [6), demonstrate a number of abnormal-
ities of the immune system. Thymus-derived lymphocytes (T-
cells) obtained from these patients show a functional defect 
[7], and monocytes from these patients demonstrate increased 
locomotion [8) and increased phagocytosis [9). Further, using 
a stain for adenosine triphosphatase (ATPase) , it has been 
reported that LC are decreased in psoriatic skin and those that 
are present are grouped in clusters [10]. On this basis, an altered 
staining pattern with anti-DR antibody would be expected in 
diseased epidermis. 
The mononuclear cell infiltrate in the dermis of a psoriatic 
plaque is composed ofT-cells [11). The recent report that the 
mononuclear cell infiltrate in the papillary dermis in lichen 
planus is composed of HLA-DR positive (HLA-DR+) T-cells 
[ 4) and the dF?monstration that activation ofT-cells can lead to 
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Ia: immune response associated antigen 
LC: Langerhans cell 
PBS: phosphate buffered saline 
PUVA: 8-methoxypsoralen plus long wavelength ultraviolet light 
R/ M-FITC: fluorescein isothiocyanate conjugated rabbit anti-
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T cells: thymus derived lymphocytes 
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expression of HLA-DR antigen by these cells [12] suggested to 
us that the mononuclear cells in the psoriatic plaque might also 
express HLA-DR. In order to explore these questions, we used 
a mouse monoclonal antibody specific for an invariant deter-
minant of the HLA-DR molecule [13] and a monoclonal panT-
cell antibody [14) to study the staining pattern in involved and 
uninvolved skin from patients with psoriasis by indirect im-
munofluorescence (IIF) light microscopy. 
MATERIALS AND METHODS 
Shin Biopsies 
To prepare frozen sections of psoriatic skin, 3-mm punch biopsy 
specimens were obtained from uninvolved and involved ru·eas of skin of 
7 patients with psoriasis who had received no therapy for 1 week or 
longer. Xylocaine, 1% without epinephrine, was used as anesthetic. For 
normal skin, tissue was obtained at surgery. All skin was immediately 
frozen in liquid nitrogen and cut into sections with a microtome 
(Lipshaw, Detroit, MI). 
Antibody 
The anti-DR antibody, called 2.06, used in the current study is a 
gamma2 immunoglobulin, which recognizes B lymphoblasto id cell lines 
and peripheral blood B cell populations but fails to react with purified 
T cells or T cell lines [13]. Antibody 2.06 recognizes all human B cells, 
regru·dless of HLA-DR type and precipitates B cell molecules of similar 
molecular weight and charge as murine Ia antigens. These data suggest 
that the antibody is du·ected against a nonpolymorphic determinant of 
HLA-DR [13]. 
MuJ"ine monoclonal anti-T cell antibody was also produced by so-
matic cell hybridization [14). This antibody, also a gamma2, has been 
shown to stain 95 to 100% of human peripheral blood T cells, but not 
B cells or monocytes. This antibody has been termed 17F12. 
As a negative control, RPC5 (Bionetics, Kensington, MD) murine 
clarified myeloma ascites protein of the same subtype (yza) as anti-
bodies 2.06 and 17F12 was used to stain tissue sections. 
Indirect. Immunofluorescence Staining 
The binding of mouse monoclonal antibody to frozen section of 
human skin was studied by IIF with fluorescein isothiocyanate conju-
gated rabbit anti-mouse immunoglobulin (R/ M-FITC) (Miles Labora-
tory, Elkru·t, IN) . Briefly, skin sections were placed on glass slides, 
labeled with the indicated monoclonal an tiserum in humidified glass 
Petri dishes for 30 min at room temperature, washed twice with 
phosphate buffered saline (PBS), labeled with the FITC second 
step reagent for 30 min at room temperature, and washed twice in PB:S 
[15]. To reduce nonspecific staining of cells with R/ M-FITC alone, this 
antibody was absorbed on a preparation of dispersed epidermal cells 
for 30 min at 4 oc before use. All antibodies were diluted in PBS to 
which s~diurn azide had been added to a level of .02%. Prepru·ations 
were covered with FA mounting fluid (DIFCO, Detroit, MI) , coverslips 
and examined with a fluorescence microscope (Zeiss, Sunnyvale, CA). 
Stain for ATPase 
To identify LC on frozen skin sections, frozen tissue was fixed in 
cacodylate-formaldehyde solution (6.85 gm sucrose, 10 ml 40% for_mal-
dehyde, 40 ml 0.2 M cacodylic acid, 50 ml distilled H20) for 20 mm at 
4°C. Following 2 washes with distilled water, the slides were incubated 
at 37°C in staining medium consisting of ATP stock and 2% Pb (NO"h 
solution [16]. The ATP stock was made of 50 mg ATP salt (Sigma, St. 
Louis, MO), 5 gm glucose, 50 rnl distilled H20 , 40 rnl Tris buffer (12.1 
gm Tris salt, 11.6 gm maleic acid, 4 gm NaOH, 400 ml H20) , 10 rnl 0.1 
M MgSO., . 7H20 . Two point seven ml of stock ATP was added to 0.3 ml 
of 2% Pb(N03 hand the slides were incubated for 60 min. After rinsing 
with distilled water, the tissue was developed in 1% yellow ammonium 
sulfide at room temperature for 20 min, rinsed in water, and mounted 
under a coverslip with glycerine jelly. 
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Stain with Hematoxylin and Eosin (H&E) 
Frozen sections of t issue were fixed in methanol, stained with Harris 
hematoxylin, dipped in acid alcohol, washed in water, stained again 
with eosin, dehydrated through alcohols, cleared in xylene and mounted 
(17]. 
RESULTS 
IIF of Psoriatic and Normal Skin 
In the involved psoriatic epidermis, the distribution of HLA-
DR+ cells was uneven. Large segments of epidermis were 
totally devoid of dendritic cells morphologically resembling LC. 
In other areas, single, dendritic cells were seen distributed 
sparsely in all epidermal cell layers from the basal layer to the 
stratum corneum (Fig lA). By contrast, poorly demarcated foci 
of clusters of brightly fluorescent cells were consistently found 
in 7 of 7 patients (Fig lB). These clusters of HLA-DR+ cells 
were relatively infrequent and were found in all levels of the 
psoriatic epidermis. This staining pattern was never observed 
in normal skin or uninvolved psoriatic epidermis obtained from 
the same patient. Tissue sections labeled with murine ascites 
protein (gamma2a) or 17F12 did not result in staining of any 
cells in the epidermis. 
FIG 1. Involved epidermis fro m a patient with psoriasis stained with 
anti HLA-DR antibody plus R/M-FITC. A, A few dendritic cells bind 
the antibody. B, In other areas, clusters of cells bind the ant ibody 
(X400). c. stratum corneum. 
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FIG 2. Uninvolved skin stained with anti HLA-DR antibody plus 
R/M-FITC. Individual HLA-DR+ dendritic cells are found in the 
epidermis (reduced from X400) . e. epidermis; d. dermis. 
FIG 3. Involved skin stained for A TPase. A group of ATPase posi-
tive cells is demonstrated in the epidermis (XlOO). e, epidermis; (->) 
dermoepidermal junction. -
For comparison, we stained a section of normal skin and 
uninvolved psoriatic skin with antibody against HLA-DR. In 
normal skin, individual dendritic cells were found randomly 
distributed above the epidermal basal cell layer as has been 
described previously [1,2]. These dendritic cells were never seen 
between basal cells or in the stratum corneum. IIF of uninvolved 
psoriatic skin revealed dendritic cells in the suprabasallayer of 
the epidermis and the arrangement of these cells was normal 
(Fig 2). In general, the number of dench·itic HLA-DR+ cells in 
this t issue appeared to be reduced compared to normal skin. 
Consecutive sections of the diseased psoriatic skin which on 
IIF showed clusters of HLA-DR+ cells in the epidermis, were 
stained for ATPase (Fig 3). Groups of ATPase positive cells, 
presumably LC were seen in the epidermis and frequently were 
clustered at the tips of dermal papillae, as has been reported 
[10]. 
In the psoriatic dermis, the anti-DR antibody labeled cells 
comprising vessel walls. These vessels showed thinning of the 
walls and dilated lumen characteristic of acanthotic psoriatic 
epidermis (Fig 4). The staining pattern of the dermal endothe-
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lial cells was not obviously altered compared to uninvolved or 
normal skin. 
Labeling of the Dermal Mononuclear Cell Infi ltrate in 
Psoriatic Plaques 
A frozen section, prepared fro m a psoriatic plaque, demon-
strated a prominent mononuclear cell infil trate in the papillary 
dermis on staining with H &E (Fig 5A ). Sections of this tissue 
when stained with antibody against HLA-DR and examined 
with the flu orescence microscope showed that the vast majority 
of the dermal mononuclear cells are DR+ (Fig 5B). Thus, the 
mononuclear cells in the dermal infil trate are either bone mar -
row-derived lymphocytes (B-cells) or activated T cells. 
T o fwt her examine this question, another biopsy which 
dem onstrated a pronounced mononuclear cell dermal infil trate 
on H &E was obtained. T wo adjacent sections were stained with 
antibody against HLA-DR and with antibody against T cells, 
respectively. Again the mononuclear cell infiltrate was HLA-
DR+ and the vast majority of these cells bound the pan T cell 
antibody (Fig 6). These cells did not bind mouse ascites protein 
of th e gamma 2,. type. Neither uninvolved psoriatic skin nor 
normal skin showed a mononuclear cell infiltrate in the dermis. 
DISCUSSION 
On fi·ozen sections of involved skin fi·om patients with pso-
riasis, the labeling pattern of antibody 2.06 is clearly different 
than that seen in either uninvolved psoriatic skin or normal 
skin. In the acanthotic epidermis, grouped HLA-DR + cells 
which are not seen in normal or uninvolved skin can be fo und 
in all layers of the psoriatic epidermis. The nature of these 
HLA-DR+ cells cannot be determined h-om om studies. How-
ever , t he stain for ATPase indicates that they may be aggre-
gated LC. 
LC are bone marrow derived lymphoid cells which express 
C3 and Fe receptor as well as HLA-DR antigens on their surface 
[18- 21]. These cells selectively take up small molecules and can 
present exogenous antigens to sensitized lymphocytes [22]. 
Moreover , LC act as stimulator cells in the mixed lymphocyte 
reaction [23]. Thus, LC represent epidermal macrophages and 
as such play an important role in contact dermatitis, and in 
allograft rejection [24]. Further, their relative density may form 
the basis for certain skin diseases [24]. H owever, the patho-
physiological mechanism by which LC influence skin disorders 
remains uncleru·. 
It has been postulated that LC may regulate keratinocyte 
proliferation [25], and recent data indicating that the keratin-
ocyte prolifera tion induced by tape stripping of the epidermis 
[26] resul ts in increased LC turnover is consistent with this 
view. Psoriasis is a disease characterized histologically and 
FrG 4. Involved skin stained with anti HLA-DR ant ibody and R/ M-
FITC. In the dermis, prominent vessels lined by brightly stained 
endothelial cells are seen (reduced fro m X400). e, epidermis; d, dermis. 
A 
FI G 5. Involved skin stained with H&E. Dense inftl trates of mono-
nuclear cells are seen in the upper dermis (A). The same section 
stained with antibody against HLA-DR plus R/ M-FITC revea ls that 
the vast majori ty of these cells are HLA-DR+ (B) (reduced from 
X250). e, epidermis; d, dermis. 
FIG 6. Involved skin stained with antibody against T cells. T he 
majori ty of dermal mononuclear cells bind this antibody (reduced from 
X250). d, dermis. 
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biochemically, by keratinocyte hyperproliferation [6,27]. Thus, 
clustering of HLA-DR+ cells in the epidermis may reflect 
migration of LC to areas of increased mitotic activity. Alterna-
tively, these HLA-DR+ cells may not be LC but represent 
groups of keratinocytes or infiltrating dermal mononuclear leu-
kocytes which express HLA-DR. 
On indirect immunofluorescence of frozen sections of normal 
skin, keratinocytes do not express HLA-DR [1,2). On the other 
hand, in certain disease states such as lichen planus and ad-
vanced stages of mycosis fungo ides, keratinocytes express HLA-
DR in- situ [ 4,5]. The failure of those authors to detect intra-
epidermal staining with antibody against HLA-DR in tissue 
from psoriatic patients [ 4] is not surprising in view of the patchy 
nature of the staining pattern. Moreover, the titer and type of 
antibody used by the 2 laboratories may differ. 
Whether the psoriatic epidermal cells which demonstrate DR 
antigen actually synthesize this protein is not clear from our 
studies. Conceivably, the visualized HLA-DR antigen is synthe-
sized by dermal mononuclear leukocytes or epidermal LC and 
is transferred to surrounding epidermal cells. Shedding of DR 
antigen by peripheral B lymphocytes has been reported [28]. 
The dermal mononuclear infiltrate itself is not a constant 
finding in patients with psoriasis. Only 2 of the 7 patients 
studied demonstrated a pronounced accumulation of mononu-
clear cells in the dermis. However, where present, these cells 
were DR+. Since these cells may represent suppressor or helper 
T cells [29], it is conceivable that they may mediate disease 
activity and that their presence may relate to the stage of the 
psoriatic disease process. 
That photochemotherapy with 8-methoxypsoralen and long 
wave-length ultraviolet light (PUV A) causes remission of pso-
riasis in most patients has been amply documented [30). More-
over, we have shown that B cells and T cells are more sensitive 
to PUV A treatment than are keratinocytes [31]. Thus, it is 
conceiva~le that PUV A treatment inhibits the epidermal hy-
perproliferation characteristic of psoriasis not by a diJ·ect effect 
on keratinocyte DNA but rather by destroying aT cell subpop-
ulation in the dermis. In this regard, it is interesting that 
cyclosporin A, a drug which has a selective inhibitory effect on 
T cells [32] exerts a beneficial effect on psoriatic skin lesions 
[33). Alternatively, PUV A may act by inhibiting or killing the 
HLA-DR+ cell aggregates in the epidermis. · 
We are grateful to Dr. E. M. Farber for his support and encourage-
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